Athanasios Garoufas is chief business development officer at Gelatex Technologies, a materials company that develops and manufactures nanofibrous scaffolds using a patented solution-spinning process. He works across wound care, drug delivery, tissue engineering, and advanced in vitro models, translating scaffold capabilities into co-development programs with industrial and academic partners. He coordinates several European research consortia in tissue engineering and advanced in vitro modeling, and focuses on how new materials move from the laboratory into routine use.